Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!

MeSH terms

• Androgen Antagonists / adverse effects
• Androgen Antagonists / therapeutic use*
• Androstenes / adverse effects
• Androstenes / therapeutic use*
• Clinical Decision-Making
• Clinical Trials, Phase III as Topic
• Docetaxel / adverse effects
• Docetaxel / therapeutic use*
• Humans
• Male
• Neoplasm Metastasis
• Patient Selection
• Progression-Free Survival
• Prostatic Neoplasms / drug therapy*
• Prostatic Neoplasms / mortality
• Prostatic Neoplasms / pathology
• Time Factors
• Treatment Outcome